Work

Treatment of Advanced Renal Cell Carcinoma with the Combination Bevacizumab/Erlotinib/Imatinib: A Phase I/II Trial

Year: 2007

Type: article

Study design: Clinical Trial

Source: Clinical Genitourinary Cancer

DOI: 10.3816/cgc.2007.n.030

Authors: John D. Hainsworth, David R. Spigel, Jeffrey A. Sosman, Howard A. Burris, Cindy Farley, Heather Cucullu, Kathleen Yost, Lowell L. Hart, Linda Sylvester, David M. Waterhouse, F. Anthony Greco

Institutions: Sarah Cannon Research Institute, Sarah Cannon, Tennessee Oncology, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Oncology Hematology Care

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2009334783

FWCI: 4.949

Cites: 20

Cited by: 80

Related to: 10